MedTrace Logo

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

NCT05076266 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2026-05-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to find out whether factors that lead Women of Color to decline participation in the breast cancer screening trial EA1151 (TMIST) differ from non-women of color.

Conditions

  • Breast Cancer, NOS

Interventions

OTHER

Questionnaire

Complete the survey questions

Sponsors & Collaborators

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Ruth Carlos · ECOG-ACRIN Cancer Research Group

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-14
Primary Completion
2023-02-02
Completion
2023-02-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05076266 on ClinicalTrials.gov